ArticleWorld journal of gastroenterology2025
Machine learning in colorectal polyp surveillance: A paradigm shift in post-endoscopic mucosal resection follow-up.
Article in World journal of gastroenterology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Colorectal cancer remains a major health concern, with colorectal polyps as key precursors. Endoscopic mucosal resection (EMR) is a common treatment, but recurrence rates remain high. Traditional surveillance strategies rely on polyp characteristics and completeness of the resection potentially missing key risk factors. Machine learning (ML) offers a transformative approach by integrating patient-specific data to refine risk stratification. Recent studies highlight ML models, such as Extreme Gradient Boosting, which outperform conventional methods in predicting polyp recurrence within one-year post-EMR. These models incorporate factors like age, smoking status, family history, and pathology, optimizing follow-up recommendations and minimizing unnecessary procedures. Artificial intelligence (AI)-driven tools and web-based calculators enhance clinical workflow by providing real-time, personalized risk assessments. However, challenges remain in external validation, model interpretability, and clinical integration. Future surveillance strategies should combine expert judgment with AI insights to optimize patient outcomes. As gastroenterology embraces AI, ML-driven surveillance represents a paradigm shift, advancing precision medicine in colorectal polyp management. This editorial explores AI's role in transforming post-EMR follow-up, addressing benefits, limitations, and future directions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.